Close Menu

NEW YORK – As demand for testing has soared during the SARS-CoV-2 pandemic, many labs with little experience in infectious disease or molecular testing have added such assays to their offerings.

And while instrument and reagent shortages have dominated discussions of the challenges laboratories faced in ramping up SARS-CoV-2 testing, lab information systems (LIS) have also proved a major chokepoint.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.